"At Lourdes Cancer Center in Binghamton, New York, our doctors and nurses listen to understand your questions and concerns and provide answers to your questions. Then we deliver a care plan with cancer-fighting treatments and support programs. Our medical, radiation and surgical oncologists, oncology-certified nurses, palliative care specialists, genetic counselors, dietitians, and rehabilitation therapists focus on your needs. We’re dedicated to helping you defeat cancer."

During the past decade, Lourdes Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lourdes Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Danish Head and Neck Cancer Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lourdes Regional Cancer Center" are "Head and Neck Cancer" (4 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (1 trials), "Cachexia" (1 trials) and "Carcinoma of Unknown Primary" (1 trials). Many other conditions were trialed in "Lourdes Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Lourdes Regional Cancer Center" are "Radiation" (7 trials), "Drug" (5 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (5 trials), "cetuximab" (2 trials), "cisplatin" (2 trials), "paclitaxel" (2 trials) and "Calcium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lourdes Regional Cancer Center" are 7 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lourdes Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Lourdes Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lourdes Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".